NCT04790968View on ClinicalTrials.gov

Combined PSMA PET/MRI for Detection of Lymph Node Metastases in High-risk Prostate Cancer Patients

NACompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

April 28, 2021

Primary Completion Date

September 30, 2024

Study Completion Date

September 30, 2024

Conditions
Prostatic NeoplasmsNeoplasm Metastasis
Interventions
DIAGNOSTIC_TEST

PSMA-PET

Prostate specific membrane antigen positron emission tomography

DIAGNOSTIC_TEST

PSMA-PET/MRI

Prostate specific membrane antigen positron emission tomography combined with magnetic resonance imaging

DIAGNOSTIC_TEST

PSMA-PET/CT

Prostate specific membrane antigen positron emission tomography combined with computed tomography imaging

Trial Locations (3)

Unknown

Haukeland University Hospital, Bergen

University Hosptial of North Norway, Tromsø

St Olavs Hospital, Trondheim University Hospital, Trondheim

All Listed Sponsors
collaborator

St. Olavs Hospital

OTHER

collaborator

Haukeland University Hospital

OTHER

collaborator

University Hospital of North Norway

OTHER

lead

Norwegian University of Science and Technology

OTHER